AccuMetab™ Human SULT1E1 Enzyme, Catalytically Active
CAT#: ITS-0426-YL85
Product Type: Recombinant Phase II Metabolizing Enzyme
Brand: AccuMetab
Development Stage: ADME
ADME Research Domain: Metabolism
Short Description
Human SULT1E1 for high-fidelity Phase II sulfation ADME assays.
Brand
AccuMetab
Development Stage
ADME
ADME Research Domain
Metabolism
Background
Known as the estrogen sulfotransferase, SULT1E1 maintains strict regulation of endogenous hormone levels and metabolizes exogenous steroidal drugs. It is a critical Phase II screening tool for developing novel hormone replacement therapies and evaluating chemical endocrine disruptors.
Key Features
High-concentration E. coli cytosol format (10 mg/mL); Premier Phase II screen for estrogenic therapeutics; Requires PAPS cofactor for rapid assay initiation; Clean, specific alternative to human liver cytosol
Applications
Phase II Drug Metabolism, Conjugation Studies
Research Areas
ADME; Phase II Conjugation
Species
Human
Expression System
Recombinant enzymes are prepared from E. coli cytosolic protein expressions.
Physical Form
Liquid
Size
1 mg
Storage
-80°C
Storage Comment
When stored at -80°C, our product remains stable and retains full functional activity for up to 10 years.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.